Introduction Kanglin Biotech (Hangzhou) Co. Ltd is a company dedicated to creating innovative gene therapy drugs for diseases such as Thalassemia, AIDS, Hemophilia and Parkinson's Disease. The company, founded in 2015 by a group of overseas-trained professionals, has made significant strides in the fields of genetic blood diseases, infectious diseases, and neurodegenerative diseases. It has been recognized with numerous honors and titles including the National High-tech Enterprise and Zhejiang Province Science and Technology Progress Award. |